3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Spinal Diseases
1
Interventions
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
cabozantinib
2
aldesleukin
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
niraparib
1
lenvatinib
1
entinostat
1
enfortumab vedotin
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
avelumab
1
Psychiatric Nursing
1
Platinum
1
Physical Therapy Modalities
1
Palliative Care
1
Paclitaxel
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Cisplatin
1
CP protocol
1
Biopsy
1
BAY 1895344
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Magnetic Resonance Imaging
×
1 year
×
Clear all
No trials found.